Compile Data Set for Download or QSAR
Report error Found 39 Enz. Inhib. hit(s) with all data for entry = 50015763
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589401(CHEMBL5169945)
Affinity DataIC50: 2nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589421(CHEMBL5187995)
Affinity DataIC50: 2nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589432(CHEMBL5178313)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589397(CHEMBL5185144)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589424(CHEMBL5187663)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589400(CHEMBL5175590)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589418(CHEMBL5183959)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589414(CHEMBL5192205)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589423(CHEMBL5175829)
Affinity DataIC50: 4nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589420(CHEMBL5181320)
Affinity DataIC50: 4nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589417(CHEMBL5198583)
Affinity DataIC50: 4nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589431(CHEMBL5200765)
Affinity DataIC50: 4.10nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589433(CHEMBL5193503)
Affinity DataIC50: 4.30nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589428(CHEMBL5207689)
Affinity DataIC50: 5nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589426(CHEMBL5178272)
Affinity DataIC50: 5nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589425(CHEMBL5208062)
Affinity DataIC50: 5nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589399(CHEMBL5201935)
Affinity DataIC50: 6nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589419(CHEMBL5184745)
Affinity DataIC50: 6nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589406(CHEMBL5188095)
Affinity DataIC50: 7nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589416(CHEMBL5177543)
Affinity DataIC50: 8nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589429(CHEMBL5173098)
Affinity DataIC50: 9nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589405(CHEMBL5170085)
Affinity DataIC50: 10nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589396(CHEMBL5170107)
Affinity DataIC50: 10nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589415(CHEMBL5189048)
Affinity DataIC50: 11nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589407(CHEMBL5179113)
Affinity DataIC50: 12nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589408(CHEMBL5185436)
Affinity DataIC50: 12nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589398(CHEMBL5184991)
Affinity DataIC50: 14nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589403(CHEMBL5178542)
Affinity DataIC50: 15nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589427(CHEMBL5208404)
Affinity DataIC50: 15nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589422(CHEMBL5209423)
Affinity DataIC50: 17nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589411(CHEMBL5187233)
Affinity DataIC50: 17nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589430(CHEMBL5206477)
Affinity DataIC50: 18nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589412(CHEMBL5202575)
Affinity DataIC50: 19nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589395(CHEMBL5201330)
Affinity DataIC50: 49nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589410(CHEMBL5180689)
Affinity DataIC50: 50nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589409(CHEMBL5181632)
Affinity DataIC50: 95nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589413(CHEMBL5187947)
Affinity DataIC50: 98nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589404(CHEMBL5181489)
Affinity DataIC50: 206nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50589402(CHEMBL5204435)
Affinity DataIC50: 711nMAssay Description:Inhibition of IRAK4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed